1. Home
  2. Labeler Index
  3. Bluepoint Laboratories
  4. 68001-345
  5. NDC Package Code: 68001-345-36 Doxorubicin Hydrochloride

NDC Package 68001-345-36 Doxorubicin Hydrochloride

Injectable, Liposomal Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68001-345-36
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE
Product Code:
68001-345
Proprietary Name:
Doxorubicin Hydrochloride
Non-Proprietary Name:
Doxorubicin Hydrochloride
Substance Name:
Doxorubicin Hydrochloride
Usage Information:
Doxorubicin hydrochloride liposome injection is contraindicated in patients who have a history of severe hypersensitivity reactions, including anaphylaxis, to doxorubicin hydrochloride [see Warnings and Precautions (5.2)].
11-Digit NDC Billing Format:
68001034536
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1790115 - DOXOrubicin HCl liposome 20 MG in 10 ML Injection
  • RxCUI: 1790115 - 10 ML doxorubicin hydrochloride liposome 2 MG/ML Injection
  • RxCUI: 1790115 - doxorubicin hydrochloride liposome 20 MG per 10 ML Injection
  • RxCUI: 1790127 - DOXOrubicin HCl liposome 50 MG in 25 ML Injection
  • RxCUI: 1790127 - 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Bluepoint Laboratories
    Dosage Form:
    Injectable, Liposomal - An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance).
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • DOXORUBICIN HYDROCHLORIDE 2 mg/mL
    • Pharmacologic Class(es):
  • Anthracycline Topoisomerase Inhibitor - [EPC] (Established Pharmacologic Class)
  • Anthracyclines - [CS]
  • Topoisomerase Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA208657
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    02-16-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 68001-345-36 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    68001034536Q2050Doxorubicin inj 10mg10 MG10122

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    68001-345-261 VIAL, SINGLE-DOSE in 1 CARTON / 25 mL in 1 VIAL, SINGLE-DOSE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 68001-345-36?

    The NDC Packaged Code 68001-345-36 is assigned to a package of 1 vial, single-dose in 1 carton / 10 ml in 1 vial, single-dose of Doxorubicin Hydrochloride, a human prescription drug labeled by Bluepoint Laboratories. The product's dosage form is injectable, liposomal and is administered via intravenous form.

    Is NDC 68001-345 included in the NDC Directory?

    Yes, Doxorubicin Hydrochloride with product code 68001-345 is active and included in the NDC Directory. The product was first marketed by Bluepoint Laboratories on February 16, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 68001-345-36?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 68001-345-36?

    The 11-digit format is 68001034536. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-268001-345-365-4-268001-0345-36